HK1072547A1 - Compositions and method for treating infection in cattle and swine - Google Patents

Compositions and method for treating infection in cattle and swine

Info

Publication number
HK1072547A1
HK1072547A1 HK05105264A HK05105264A HK1072547A1 HK 1072547 A1 HK1072547 A1 HK 1072547A1 HK 05105264 A HK05105264 A HK 05105264A HK 05105264 A HK05105264 A HK 05105264A HK 1072547 A1 HK1072547 A1 HK 1072547A1
Authority
HK
Hong Kong
Prior art keywords
swine
cattle
compositions
treating infection
infection
Prior art date
Application number
HK05105264A
Other languages
English (en)
Inventor
Kohan Raul
Varma Kanwal
Simmons Robert
Huq Abu
Freehauf Keith
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of HK1072547A1 publication Critical patent/HK1072547A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HK05105264A 2002-05-20 2005-06-23 Compositions and method for treating infection in cattle and swine HK1072547A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38201502P 2002-05-20 2002-05-20
PCT/IB2003/002152 WO2003097054A1 (en) 2002-05-20 2003-05-19 Compositions and method for treating infection in cattle and swine

Publications (1)

Publication Number Publication Date
HK1072547A1 true HK1072547A1 (en) 2005-09-02

Family

ID=29550174

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05105264A HK1072547A1 (en) 2002-05-20 2005-06-23 Compositions and method for treating infection in cattle and swine

Country Status (29)

Country Link
US (3) US6790867B2 (zh)
EP (1) EP1505975B1 (zh)
JP (2) JP4772324B2 (zh)
KR (1) KR101102176B1 (zh)
CN (1) CN100563655C (zh)
AR (1) AR039826A1 (zh)
AU (1) AU2003228042B2 (zh)
BR (1) BRPI0311126B1 (zh)
CA (1) CA2485491C (zh)
CY (1) CY1107176T1 (zh)
DE (1) DE60317662T2 (zh)
DK (1) DK1505975T3 (zh)
EC (1) ECSP045442A (zh)
ES (1) ES2295583T3 (zh)
HK (1) HK1072547A1 (zh)
IL (2) IL165252A0 (zh)
MX (1) MXPA04011516A (zh)
MY (1) MY135791A (zh)
NO (1) NO20045547L (zh)
NZ (1) NZ536476A (zh)
PE (1) PE20040041A1 (zh)
PL (1) PL213975B1 (zh)
PT (1) PT1505975E (zh)
RU (2) RU2330662C2 (zh)
SI (1) SI1505975T1 (zh)
TW (1) TWI355266B (zh)
UA (1) UA81629C2 (zh)
WO (1) WO2003097054A1 (zh)
ZA (1) ZA200409296B (zh)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US6432203B1 (en) * 1997-03-17 2002-08-13 Applied Komatsu Technology, Inc. Heated and cooled vacuum chamber shield
US20070003508A1 (en) 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
US20040208842A1 (en) * 2001-09-18 2004-10-21 Ritchie Branson W. Antimicrobial cleansing compositions and methods of use
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
BRPI0213425B8 (pt) * 2001-10-19 2021-05-25 Idexx Lab Inc composições injetáveis para a liberação controlada de composto farmacologicamente ativo, usos do referido composto e método para suas preparações
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
WO2005044254A1 (en) * 2003-10-29 2005-05-19 Idexx Laboratories, Inc. Salts of pharmacologically active compounds
KR100548948B1 (ko) * 2003-11-24 2006-02-02 주식회사 한동 플로르페니콜의 약제학적 조성물
US20070185202A1 (en) * 2004-03-03 2007-08-09 University Of Georgia Research Foundation, Inc. Methods and compositions for ophthalmic treatment of fungal and bacterial infections
US7402697B2 (en) * 2004-09-02 2008-07-22 Idexx Laboratories Inc. Antibacterial agents
ES2315942T3 (es) * 2004-12-21 2009-04-01 Intervet International Bv Composicion veterinaria inyectable que contiene florfenicol.
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US7518017B2 (en) 2006-02-17 2009-04-14 Idexx Laboratories Fenicol compounds and methods synthesizing 2-trifluoroacetamido-3-substituted propiophenone compounds
CA2672586A1 (en) * 2006-12-13 2008-06-26 Schering-Plough Ltd. Water-soluble prodrugs of florfenicol and its analogs
US8044230B2 (en) * 2006-12-13 2011-10-25 Intervet Inc. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
KR20090090387A (ko) * 2006-12-19 2009-08-25 쉐링-프라우 리미티드 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
EP2150245A1 (en) * 2007-04-27 2010-02-10 Schering-Plough Ltd. Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
US7550625B2 (en) 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
US20090170954A1 (en) * 2007-12-14 2009-07-02 Schering-Plough Ltd. Process for Recovering Florfenicol and Florfenicol Analogs
CA2708409A1 (en) 2007-12-14 2009-06-25 Intervet International B.V. Process for recovering flunixin from pharmaceutical compositions
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
WO2009143558A1 (en) * 2008-05-26 2009-12-03 Silphion Pty Limited Injectable formulations
CN101461821B (zh) * 2008-07-04 2011-05-18 青岛康地恩药业有限公司 一种用于治疗猪、牛呼吸道疾病的复方口服药物组合物
UA118536C2 (uk) 2008-07-23 2019-02-11 Амбркс, Інк. Модифікований поліпептид бичачого гранулоцитарного колонієстимулювального фактора та його застосування
CA2732017A1 (en) * 2008-07-30 2010-02-04 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
BRPI1002021A2 (pt) * 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
CN102188422B (zh) * 2011-01-11 2013-11-06 广东大华农动物保健品股份有限公司 一种复方氟苯尼考注射液及其制备方法和应用
EA019956B1 (ru) * 2011-02-24 2014-07-30 Закрытое Акционерное Общество "Нита-Фарм" Фармацевтическая композиция для лечения заболеваний бактериальной и микоплазменной этиологии
UA110436C2 (en) * 2012-03-06 2015-12-25 Zoetis Llc Antibacterial phenol compounds
EP2900641A1 (en) * 2012-09-26 2015-08-05 Zoetis LLC Phenicol antibacterial agents
CN102920701A (zh) * 2012-11-02 2013-02-13 青岛康地恩药业股份有限公司 一种用于治疗猪呼吸道感染疾病的复方氟苯尼考制剂及其制备方法
CN104208062A (zh) * 2013-06-03 2014-12-17 中国农业科学院兰州畜牧与兽药研究所 一种高浓度复方氟苯尼考注射液及其制备方法和应用
CN104188901A (zh) * 2014-08-12 2014-12-10 河南迪冉生物科技有限公司 一种兽用氟苯尼考注射液及其制备方法
CN104095996A (zh) * 2014-08-12 2014-10-15 王忠亮 一种治疗急性脓肿期乳腺炎的药物组合物
CN104370782A (zh) * 2014-11-29 2015-02-25 郑州后羿制药有限公司 一种氟苯尼考的精制方法
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
CN108904442B (zh) * 2018-08-09 2021-04-06 山西瑞象生物药业有限公司 一种氟苯尼考溶液剂及其制备方法
JP2021536485A (ja) * 2018-09-06 2021-12-27 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 注射可能な徐放性の抗生物質製剤
CN110208397B (zh) * 2019-05-17 2022-08-19 河北远征药业有限公司 一种同时测定土霉素氟尼辛注射液中两种主药含量的高效液相色谱法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3025325A1 (de) * 1980-07-04 1982-02-04 Merck Patent Gmbh, 6100 Darmstadt Neue 13-thiaprostaglandin-zwischenprodukte, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von 13-thiaprostaglandin-derivaten
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
AU731799B2 (en) 1997-05-06 2001-04-05 Norbrook Laboratories Limited Improvements in or relating to long-acting antimicrobials
JP2003512290A (ja) * 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
PL351710A1 (en) * 1999-05-14 2003-06-02 Univ California Anti−inflammatory therapy for inflammatory mediated infection
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US6790867B2 (en) 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino

Also Published As

Publication number Publication date
RU2466726C2 (ru) 2012-11-20
US6790867B2 (en) 2004-09-14
SI1505975T1 (sl) 2008-06-30
TW200307536A (en) 2003-12-16
TWI355266B (en) 2012-01-01
RU2008107582A (ru) 2009-09-10
CA2485491A1 (en) 2003-11-27
EP1505975A1 (en) 2005-02-16
RU2004137273A (ru) 2005-07-10
DE60317662D1 (de) 2008-01-03
BR0311126A (pt) 2005-03-08
CY1107176T1 (el) 2012-10-24
AU2003228042B2 (en) 2006-09-21
WO2003097054A1 (en) 2003-11-27
UA81629C2 (ru) 2008-01-25
RU2330662C2 (ru) 2008-08-10
NO20045547L (no) 2004-12-17
AU2003228042A1 (en) 2003-12-02
PL213975B1 (pl) 2013-05-31
EP1505975B1 (en) 2007-11-21
PT1505975E (pt) 2008-01-31
JP2006213731A (ja) 2006-08-17
NZ536476A (en) 2008-10-31
PE20040041A1 (es) 2004-01-24
US20050288261A1 (en) 2005-12-29
US20030220302A1 (en) 2003-11-27
ES2295583T3 (es) 2008-04-16
DE60317662T2 (de) 2008-10-30
IL165252A0 (en) 2005-12-18
US8044102B2 (en) 2011-10-25
MY135791A (en) 2008-06-30
AR039826A1 (es) 2005-03-02
BRPI0311126B1 (pt) 2016-11-08
MXPA04011516A (es) 2005-02-14
JP4772324B2 (ja) 2011-09-14
ECSP045442A (es) 2005-01-03
US20030216447A1 (en) 2003-11-20
KR20050010818A (ko) 2005-01-28
CN100563655C (zh) 2009-12-02
ZA200409296B (en) 2005-07-27
IL165252A (en) 2011-11-30
JP2005526849A (ja) 2005-09-08
DK1505975T3 (da) 2008-01-14
CA2485491C (en) 2012-12-04
KR101102176B1 (ko) 2012-01-02
PL374575A1 (en) 2005-10-31
CN1652783A (zh) 2005-08-10

Similar Documents

Publication Publication Date Title
HK1072547A1 (en) Compositions and method for treating infection in cattle and swine
IL172224A0 (en) Compositions for treating infection in cattle and swine
EP1701664A4 (en) SYSTEM AND METHOD FOR PROCESSING A FABRIC
AU2003284242A8 (en) Methods and compositions for use in treating cancer
ZA200507857B (en) Compositions for treating microbial and parasitic infections in cattle and other animals
AU2003218580A1 (en) Methods and apparatus for treating animal manure
HK1074005A1 (en) Compositions and methods for treating or preventing pneumococcal infection
GB0110288D0 (en) Composition and treatment method
GB0609689D0 (en) Non-nucleotide compositions and method for treating pain
EP1468118A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
IL164219A0 (en) Method for treating and preventing hyparathyroidism
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
AU2003232044A8 (en) Composition and method for dermatological treatment
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
ZA200602275B (en) Composition and method for treating bezoar and trichobezoar
IL166062A0 (en) Compositions and methods for therapeutic treatment
AU2003275433A8 (en) Compositions and methods for treating pain
EP1608232A4 (en) METHOD AND COMPOSITIONS FOR IMPROVING ANIMAL HEALTH
AU2003269378A8 (en) Methods and compositions for diagnosing and treating companion animal cancer
AU2003298708A8 (en) Gpc99 and gpc99a: methods and compositions for treating cancer
EP1261331A4 (en) METHOD AND COMPOSITIONS FOR TREATING FIBROSANT DISEASES
GB0323849D0 (en) Animal treatment system and method thereof
AU2003256678A8 (en) Method and composition for treating and preventing hepatitis c infection
AU2003259198A8 (en) Method and composition for treating and preventing influenza infection and symptoms thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140519